Conference LibraryGated
EsoBiotec 2024-12-11 PR · IIT initiation · ESO-T01 in China
EsoBiotec 公司官方 PR (2024-12-11) · 宣布在中国启动 ESO-T01 BCMA CAR-T 的 investigator-initiated trial · CEO Jean-Pierre Latere, Ph.D. · CSO Philippe Parone, Ph.D. · 公司 HQ Mont-Saint-Guibert, Belgium · ENaBL (Engineered NanoBody Lentiviral) 第三代 immune-shielded lentiviral vector platform · T…
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_intel_seed_2026-05-16
- evidence_grade
- A
- category
- company_press_release
- status
- verified
- instance_tag
- sunvax-antibody-2025
- journal
- EsoBiotec corporate press release
- year
- 2024
- authors
- abstract_snippet
- EsoBiotec 公司官方 PR (2024-12-11) · 宣布在中国启动 ESO-T01 BCMA CAR-T 的 investigator-initiated trial · CEO Jean-Pierre Latere, Ph.D. · CSO Philippe Parone, Ph.D. · 公司 HQ Mont-Saint-Guibert, Belgium · ENaBL (Engineered NanoBody Lentiviral) 第三代 immune-shielded lentiviral vector platform · T
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.